LIQUIFILM TEARS Eye drops, solution Ref.[49868] Active ingredients: Polyvinyl alcohol

Source: Health Products Regulatory Authority (IE)  Revision Year: 2009  Publisher: Allergan Pharmaceuticals Ireland, Castlebar Road, Westport, County Mayo

4.3. Contraindications

Hypersensitivity to the active substance or to any of the excipients.

Use with soft contact lenses.

4.4. Special warnings and precautions for use

If irritation, pain, redness and changes in vision occur or worsen or persist for more than 72 hours, treatment should be discontinued and a new assessment considered.

To avoid contamination, the dropper tip should not be allowed to touch the eye or any other surface.

Contact lenses should be removed before each application and may be reinserted after 15 minutes.

Liquifilm Tears contain benzalkonium chloride which is irritant to the eye and could cause discolouration of soft lenses. Avoid contact with soft contact lenses. Remove contact lenses before Liquifilm Tears is used and wait for at least 15 minutes before reinsertion.

Concomitant ocular medication should be administered 15 minutes prior to the instillation of Liquifilm Tears.

4.5. Interaction with other medicinal products and other forms of interaction

No interaction studies have been performed.

4.6. Pregnancy and lactation

The constituents of Liquifilm Tears have been used as pharmaceutical agents for many years with no untoward effects. No special precautions are necessary for the use of Liquifilm Tears in pregnancy and lactation.

4.7. Effects on ability to drive and use machines

No studies on the effects on the ability to drive and use machines have been performed.

Based upon the information available, Liquifilm Tears has no or negligible influence on the ability to drive and use machines. However, it may cause transient blurring of vision. Do not drive or use hazardous machinery unless vision is clear.

4.8. Undesirable effects

The following undesirable effects have been reported since Liquifilm Tears was marketed.

Frequency:

Not known: the incidence cannot be determined from available information.

Eye disorders

Not known: eye irritation, eye pain, ocular hyperaemia, lacrimation increased, foreign body sensation, eye pruritus.

Immune system disorders

Not known: hypersensitivity.

6.2. Incompatibilities

Not applicable.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.